Safety Profile in Research Contexts Gastrointestinal events (nausea, vomiting, diarrhea, constipation) remain the most common adverse effects, typically mild to moderate, dose-dependent, and often mitigated by gradual dose escalation starting at lower levels (e.g., 2 mg)
In these instances, we work on lifestyle modification and collaborate with our endobariatric colleagues to provide the latest minimally invasive techniques for managing weight regain, while also using medications like GLP-1 receptor agonists to help people achieve the healthiest weight possible
Cannot redeclare control with same name "grid_3_qv_background_attachment"
Omoto, Y
Evidence remains largely preclinical, which requires cautious interpretation of both benefits and safety
A pinch of salt in water or a sugar-free electrolyte mix usually clears it up fast